Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 13Gastrointestinal 9Thoracic 7Other hematologic neoplasm 6Genitourinary 5Tumor-Agnostic 3Gynecologic 3Sarcoma 2Plasma cell 2Other solid neoplasm 2Myeloid 2Head & Neck 2Dermatologic 2Lymphoid 1Endocrine 1Classical hematology 1

Conditions

Multiple Myeloma 2

Interventions

Dexamethasone 393Bortezomib 246Lenalidomide 222Cyclophosphamide 184Melphalan 168Calcium Dobesilate 119Peripheral Blood Stem Cell Transplantation 94fludarabine phosphate 89Thalidomide 82Filgrastim 74carfilzomib 70pomalidomide 68Granulocyte Colony-Stimulating Factor 63Busulfan 63Mycophenolic Acid 61daratumumab 58Whole-Body Irradiation 57ixazomib 54fludarabine 52Tacrolimus 52Prednisone 51Cyclosporine 50Antilymphocyte Serum 35dexamethasone acetate 32plerixafor 30Etoposide 30Methotrexate 29Radiotherapy 28dexamethasone 21-phosphate 27Doxorubicin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Practice Guidelines as Topic × Plasma cell × Clear all
NCT05142371 2025-05-30

Telehealth Exercise Intervention to Improve Physical Function and Frailty in Multiple Myeloma Survivors

City of Hope Medical Center

Phase NA Completed
33 enrolled
Plasma cell

Multiple Myeloma

NCT04530812 2021-11-16

Fermented Milk Supplementation on Symptoms of Disease and Treatment in Patients With Multiple Myeloma

Roswell Park Cancer Institute

Phase NA Completed
13 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡